-
Exceeds High End of Revenue Guidance Range by 37%, Representing 222%
Year-Over-Year Growth
-
Completed Acquisition of Oxford Ionics and Vector Atomic,
Accelerating and Strengthening IonQ’s Full Stack Quantum Platform
-
Achieved World-Record 99.99% Two-Qubit Gate Performance, Becoming
First to Secure Fidelity Required to Scale to Full Fault-Tolerant
Quantum Computing
-
Achieved 2025 Technical Milestone of #AQ 64 on IonQ Tempo Three
Months Ahead of Schedule, Unlocking 36 Quadrillion Times Larger
Computational Space Than Leading Commercial Superconducting Systems
-
Awarded New Contract with Oak Ridge National Laboratory to Develop
Advanced Energy Applications and Accelerate Quantum-Classical
Workflows
-
Pro-Forma Cash, Cash Equivalents, and Investments as of September 30,
2025 of $3.5 Billion After $2 Billion Equity Offering on October 14,
2025
COLLEGE PARK, Md.--(BUSINESS WIRE)--
IonQ (NYSE: IONQ), the world’s leading quantum company, today announced
financial results for the quarter ended September 30, 2025.
"I am pleased to report that we once again beat the high end of our revenue
guidance, this time by 37%. We are also raising our revenue expectations for
the full year to $110 million at the high end of guidance,” said Niccolo de
Masi, Chairman and CEO of IonQ. “We delivered our 2025 technical milestone
of #AQ 64 three months early, unlocking 36 quadrillion times more
computational space than leading commercial superconducting systems. We
achieved a truly historic milestone by demonstrating world-record 99.99%
two-qubit gate performance, underscoring our path to 2 million qubits and
80,000 logical qubits in 2030.”
“Our technical achievements continue to solidify IonQ’s quantum platform as
the most complete and powerful in the world, with a correspondingly larger
addressable global market,” de Masi continued. “Our Electronic Qubit Control
systems and world-record fidelity, combined with uniquely low unit economics
at full fault tolerance, underpin IonQ as the global leader in a class of
its own in quantum computing. Meanwhile, we are on a clear trajectory to
deliver critical quantum cybersecurity infrastructure, ultra-precise quantum
navigation, quantum timing solutions, and large-scale networked quantum
systems.”
de Masi concluded, “Now with $3.5 billion of pro-forma net cash, we are
continuing to reap the compounding benefits of our scale and momentum
advantages, entrenching our position as the dominant force in quantum and
the only complete platform solution. I am confident in our ability to
deliver growth and value creation for IonQ shareholders in 2026.”
Financial Highlights
-
IonQ recognized revenue of $39.9 million for the third quarter, which is
37% above the top end of the previously provided range and represents 222%
year-over-year growth.
-
Cash, cash equivalents, and investments were $1.5 billion as of September
30, 2025 and $3.5 billion pro-forma for the $2 billion equity offering
that closed on October 14, 2025.
-
Net loss was $1.1 billion, Adjusted EBITDA loss was $48.9 million, GAAP
EPS was ($3.58) and Adjusted EPS was ($0.17) for the third quarter.*
*Adjusted EBITDA and Adjusted EPS are non-GAAP financial measures defined
under “Non-GAAP Financial Measures,” below, and are reconciled to net loss
and GAAP EPS, the closest comparable GAAP measures, respectively, at the
end of this release.
Q3 and Recent Commercial Highlights
Q3 and Recent Technical Highlights
Q3 and Recent Corporate Highlights
-
IonQ completed its acquisition of Oxford Ionics, enabling scale, stability, and cost-savings by leveraging existing
semiconductor manufacturing.
-
IonQ completed its acquisition of Vector Atomic, strengthening IonQ’s full-stack quantum platform by adding the world’s
most advanced quantum sensing capabilities.
-
IonQ priced and completed a $2.0 billion equity offering, including shares and warrants, to facilitate global growth and
accelerate IonQ’s quantum commercialization worldwide.
-
IonQ created IonQ Federal
to meet increasing demand for quantum advantage across the U.S. and allied
governments, and
appointed Dean Acosta
Chief Corporate Affairs and Government Relations Officer, bringing more
than three decades of experience in technology, defense and public
service.
-
IonQ appointed Inder M. Singh
Chief Financial Officer and Chief Operating Officer, bringing significant
financial acumen and more than three decades of experience guiding
companies through periods of rapid and transformative growth.
- IonQ appointed Dr. Chris Ballance, President of Quantum Computing.
-
IonQ appointed Dr. Marco Pistoia, CEO of IonQ Italia, as IonQ continues to
deepen its investments in EMEA.
-
IonQ hosted its 2025 Analyst Day, providing in-depth updates on business strategy, technology roadmap,
and vision for its commercial quantum platform from a broad bench of
leaders across corporate, government and academic domain expertise.
2025 Financial Outlook
-
For the full year 2025, IonQ is raising its revenue expectations to
between $106 million and $110 million.
-
For the full year 2025, IonQ is reaffirming its Adjusted EBITDA loss
midpoint guidance with a range of between ($206) million and ($216)
million.*
*Adjusted EBITDA is a non-GAAP financial measure defined under “Non-GAAP
Financial Measures,” below. The Company is unable to provide a
reconciliation of forward-looking Adjusted EBITDA without unreasonable
effort because of the uncertainty and potential variability in amount and
timing of certain charges, including the change in the fair value of
warrant liabilities, which are reconciling items between GAAP net loss and
Adjusted EBITDA and could significantly impact GAAP results.
Upcoming Q4 2025 Conference Participation
-
IonQ to participate in the Bank of America 2025 Transforming World
Conference taking place on Wednesday November 12, 2025. A webcast link to
the keynote presentation will be available on our investor relations
website.
-
IonQ to participate in the UBS Global Technology Conference taking place
on Monday, December 1, 2025. A webcast link will be available on our
investor relations website.
Third Quarter 2025 Conference Call
IonQ will host a conference call today at 4:30 p.m. Eastern time to review
the Company’s financial results for the third quarter ended September 30,
2025 and to provide a business update. The call will be accessible by
telephone at 844-826-3035 (domestic) or +1-412-317-5195 (international). The
call will also be available live via webcast on the Company’s website
here, or directly
here. A telephone replay of the conference call will be available approximately
three hours after its conclusion at 844-512-2921 (domestic) or
+1-412-317-6671 (international) with access code 10203563 and will be
available until 11:59 PM Eastern time, November 19, 2025. An archive of the
webcast will also be available
here
shortly after the call and will remain available for one year.
Non-GAAP Financial Measures
To supplement IonQ’s condensed consolidated financial statements presented
in accordance with GAAP, IonQ uses non-GAAP measures of certain components
of financial performance. Adjusted EBITDA and Adjusted EPS are financial
measures that are not required by or presented in accordance with GAAP.
Management believes that these measures provide investors additional
meaningful methods to evaluate certain aspects of the Company’s results
period over period.
Adjusted EBITDA is defined as net loss attributable to IonQ, Inc. before net
loss attributable to noncontrolling interests, interest income, interest
expense, income tax (benefit) expense, depreciation and amortization,
stock-based compensation, executive cash-based severance, change in fair
value of warrant liabilities, offering costs associated with warrants and
acquisition transaction and integration costs. Adjusted EPS is defined as
earnings per share, or EPS, excluding the impact of stock-based
compensation, executive cash-based severance, change in fair value of
warrant liabilities, offering costs associated with warrants and acquisition
transaction and integration costs. IonQ uses Adjusted EBITDA and Adjusted
EPS to measure the operating performance of its business, excluding
specifically identified items that it does not believe directly reflect its
core operations and that may not be indicative of recurring operations.
The presentation of these non-GAAP financial measures is not meant to be
considered in isolation or as a substitute for the financial results
prepared in accordance with GAAP, and IonQ’s non-GAAP measures may be
different from non-GAAP measures used by other companies. IonQ shows a
reconciliation of its non-GAAP measures to the most directly comparable GAAP
measures at the end of this release.
About IonQ
IonQ, Inc.
[NYSE: IONQ] is the world’s leading quantum company delivering solutions to
solve the world’s most complex problems. IonQ’s newest generation quantum
computers,
IonQ Tempo
and
IonQ Forte Enterprise, are the latest in cutting-edge systems that have been helping customers
and partners such as
Amazon Web Services, AstraZeneca, and NVIDIA
achieve 20x performance results. The company achieved 99.99% two-qubit gate
fidelity, setting a world record in quantum computing performance in 2025.
The company is accelerating its technology roadmap and intends to deliver
the world’s most powerful quantum computers with 2 million qubits by 2030 to
accelerate innovation in drug discovery, materials science, financial
modeling, logistics, cybersecurity, and defense. IonQ’s advancements in
quantum networking position the company as a leader in building the quantum
internet.
IonQ has operations in Maryland, Washington, California, Colorado,
Massachusetts, Tennessee, United Kingdom, Toronto, South Korea, Sweden, and
Switzerland. The company’s innovative technology and rapid growth were
recognized in Fortune Future 50, Newsweek’s 2025 Excellence Index 1000, and
Forbes’ 2025 Most Successful Mid-Cap Companies list. Available through all
major cloud providers, IonQ is making quantum more accessible and impactful
than ever before. Learn more at
IonQ.com.
Note to Investors Regarding Forward-Looking Statements
This press release contains forward-looking statements. All statements
contained in this press release other than statements of historical fact are
forward-looking statements, including statements regarding our guidance as
to future financial and operational results and our ability to deliver
growth and value creation for stockholders. In some cases, you can identify
these statements by forward-looking words such as “pending,” “look forward,”
“accelerate,” “anticipate,” “expect,” “suggest,” “plan,” “believe,”
“intend,” “estimate,” “target,” “project,” “should,” “could,” “would,”
“may,” “will,” “forecast,” “confident” and other similar expressions. These
statements are only predictions based on our expectations and projections
about future events as of the date of this press release and are subject to
a number of risks, uncertainties and assumptions that may prove incorrect,
any of which could cause actual results to differ materially from those
expressed or implied by such statements, including, among others, those
described under the heading “Risk Factors” in our Annual Report on Form 10-K
for the year ended December 31, 2024 filed with the Securities and Exchange
Commission, or SEC, and our Quarterly Reports on Form 10-Q for the quarters
ended March 31, 2025, June 30, 2025 and September 30, 2025 filed with the
SEC. New risks emerge from time to time, and it is not possible for our
management to predict all risks, nor can management assess the impact of all
factors on our business or the extent to which any factor, or combination of
factors, may cause actual results to differ materially from those contained
in any forward-looking statement we make. Investors are cautioned not to
place undue reliance on any such forward-looking statements, which speak
only as of the date they are made. Except as otherwise required by law, we
undertake no obligation to update any forward-looking statement, whether as
a result of new information, future events or otherwise.
IonQ, Inc.
Condensed Consolidated Statements of Operations
(unaudited)
(in thousands, except share and per share data)
|
|
|
Three Months Ended September 30,
|
|
|
Nine Months Ended September 30,
|
|
|
|
|
2025
|
|
|
2024
|
|
|
2025
|
|
|
2024
|
|
|
Revenue
|
|
$
|
39,866
|
|
|
$
|
12,400
|
|
|
$
|
68,126
|
|
|
$
|
31,363
|
|
|
Costs and expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of revenue (excluding depreciation and amortization)
|
|
|
21,253
|
|
|
|
6,515
|
|
|
|
33,895
|
|
|
|
15,552
|
|
|
Research and development
|
|
|
66,298
|
|
|
|
33,178
|
|
|
|
209,610
|
|
|
|
96,750
|
|
|
Sales and marketing
|
|
|
14,441
|
|
|
|
6,630
|
|
|
|
33,928
|
|
|
|
19,468
|
|
|
General and administrative
|
|
|
82,505
|
|
|
|
14,322
|
|
|
|
154,418
|
|
|
|
41,395
|
|
|
Depreciation and amortization
|
|
|
24,182
|
|
|
|
4,890
|
|
|
|
41,359
|
|
|
|
13,150
|
|
|
Total operating costs and expenses
|
|
|
208,679
|
|
|
|
65,535
|
|
|
|
473,210
|
|
|
|
186,315
|
|
|
Loss from operations
|
|
|
(168,813
|
)
|
|
|
(53,135
|
)
|
|
|
(405,084
|
)
|
|
|
(154,952
|
)
|
|
Gain (loss) on change in fair value of warrant liabilities
|
|
|
(881,847
|
)
|
|
|
(3,868
|
)
|
|
|
(882,930
|
)
|
|
|
11,398
|
|
|
Interest income, net
|
|
|
14,437
|
|
|
|
4,508
|
|
|
|
26,469
|
|
|
|
14,108
|
|
|
Offering costs associated with warrants
|
|
|
(22,847
|
)
|
|
|
—
|
|
|
|
(22,847
|
)
|
|
|
—
|
|
|
Other income (expense), net
|
|
|
(980
|
)
|
|
|
15
|
|
|
|
(697
|
)
|
|
|
(164
|
)
|
|
Loss before income tax expense
|
|
|
(1,060,050
|
)
|
|
|
(52,480
|
)
|
|
|
(1,285,089
|
)
|
|
|
(129,610
|
)
|
|
Income tax benefit (expense)
|
|
|
4,438
|
|
|
|
(16
|
)
|
|
|
19,695
|
|
|
|
(39
|
)
|
|
Net loss
|
|
$
|
(1,055,612
|
)
|
|
$
|
(52,496
|
)
|
|
$
|
(1,265,394
|
)
|
|
$
|
(129,649
|
)
|
|
Net loss attributable to noncontrolling interests
|
|
|
(657
|
)
|
|
|
—
|
|
|
|
(1,349
|
)
|
|
|
—
|
|
|
Net loss attributable to IonQ, Inc.
|
|
$
|
(1,054,955
|
)
|
|
$
|
(52,496
|
)
|
|
$
|
(1,264,045
|
)
|
|
$
|
(129,649
|
)
|
|
Net loss per share attributable to IonQ, Inc. common
stockholders—basic and diluted
|
|
$
|
(3.58
|
)
|
|
$
|
(0.24
|
)
|
|
$
|
(4.89
|
)
|
|
$
|
(0.61
|
)
|
|
Weighted average shares used in computing net loss per share
attributable to IonQ, Inc. common stockholders—basic and
diluted
|
|
|
294,524,786
|
|
|
|
214,305,053
|
|
|
|
258,324,714
|
|
|
|
211,378,045
|
|
IonQ, Inc.
Condensed Consolidated Balance Sheets
(unaudited)
(in thousands)
|
|
|
September 30,
|
|
|
December 31,
|
|
|
|
|
2025
|
|
|
2024
|
|
|
Assets
|
|
|
|
|
|
|
|
Current assets:
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
346,032
|
|
|
$
|
54,393
|
|
|
Short-term investments
|
|
|
736,333
|
|
|
|
285,896
|
|
|
Accounts receivable, net
|
|
|
36,912
|
|
|
|
10,188
|
|
|
Prepaid expenses and other current assets
|
|
|
96,025
|
|
|
|
28,325
|
|
|
Total current assets
|
|
|
1,215,302
|
|
|
|
378,802
|
|
|
Long-term investments
|
|
|
402,603
|
|
|
|
23,545
|
|
|
Property and equipment, net
|
|
|
119,564
|
|
|
|
52,761
|
|
|
Operating lease right-of-use assets
|
|
|
20,940
|
|
|
|
9,470
|
|
|
Intangible assets, net
|
|
|
655,909
|
|
|
|
29,469
|
|
|
Goodwill
|
|
|
1,865,841
|
|
|
|
9,904
|
|
|
Other noncurrent assets
|
|
|
39,189
|
|
|
|
4,437
|
|
|
Total Assets
|
|
$
|
4,319,348
|
|
|
$
|
508,388
|
|
|
Liabilities and Stockholders’ Equity
|
|
|
|
|
|
|
|
Current liabilities:
|
|
|
|
|
|
|
|
Accounts payable
|
|
$
|
16,970
|
|
|
$
|
5,230
|
|
|
Accrued expenses and other current liabilities
|
|
|
91,856
|
|
|
|
16,811
|
|
|
Current portion of operating lease liabilities
|
|
|
8,599
|
|
|
|
3,366
|
|
|
Unearned revenue
|
|
|
21,855
|
|
|
|
10,678
|
|
|
Total current liabilities
|
|
|
139,280
|
|
|
|
36,085
|
|
|
Operating lease liabilities, net of current portion
|
|
|
19,917
|
|
|
|
14,359
|
|
|
Unearned revenue, net of current portion
|
|
|
3,384
|
|
|
|
—
|
|
|
Warrant liabilities
|
|
|
1,768,232
|
|
|
|
70,688
|
|
|
Other noncurrent liabilities
|
|
|
100,736
|
|
|
|
3,394
|
|
|
Total liabilities
|
|
$
|
2,031,549
|
|
|
$
|
124,526
|
|
|
Stockholders’ Equity:
|
|
|
|
|
|
|
|
Common stock
|
|
$
|
32
|
|
|
$
|
22
|
|
|
Additional paid-in capital
|
|
|
4,237,882
|
|
|
|
1,067,403
|
|
|
Accumulated deficit
|
|
|
(1,947,765
|
)
|
|
|
(683,720
|
)
|
|
Accumulated other comprehensive income (loss)
|
|
|
(16,788
|
)
|
|
|
157
|
|
|
Total IonQ, Inc. stockholders’ equity
|
|
$
|
2,273,361
|
|
|
$
|
383,862
|
|
|
Noncontrolling interests
|
|
|
14,438
|
|
|
|
—
|
|
|
Total stockholders’ equity
|
|
$
|
2,287,799
|
|
|
|
383,862
|
|
|
Total Liabilities and Stockholders’ Equity
|
|
$
|
4,319,348
|
|
|
$
|
508,388
|
|
IonQ, Inc.
Condensed Consolidated Statements of Cash Flows
(unaudited)
(in thousands)
|
|
|
Nine Months Ended September 30,
|
|
|
|
|
2025
|
|
|
2024
|
|
|
Cash flows from operating activities:
|
|
|
|
|
|
|
|
Net loss
|
|
$
|
(1,265,394
|
)
|
|
$
|
(129,649
|
)
|
|
Adjustments to reconcile net loss to net cash used in operating
activities:
|
|
|
|
|
|
|
|
Depreciation and amortization
|
|
|
41,359
|
|
|
|
13,150
|
|
|
Stock-based compensation
|
|
|
205,366
|
|
|
|
67,607
|
|
|
(Gain) loss on change in fair value of warrant liabilities
|
|
|
882,930
|
|
|
|
(11,398
|
)
|
|
Deferred income taxes
|
|
|
(19,885
|
)
|
|
|
—
|
|
|
Amortization of premiums and accretion of discounts on
available-for-sale securities
|
|
|
(6,167
|
)
|
|
|
(7,086
|
)
|
|
Other, net
|
|
|
5,872
|
|
|
|
4,291
|
|
|
Changes in operating assets and liabilities:
|
|
|
|
|
|
—
|
|
|
Accounts receivable
|
|
|
(15,849
|
)
|
|
|
7,341
|
|
|
Prepaid expenses and other current assets
|
|
|
(42,572
|
)
|
|
|
(9,899
|
)
|
|
Accounts payable
|
|
|
(17,413
|
)
|
|
|
(463
|
)
|
|
Accrued expenses and other current liabilities
|
|
|
27,777
|
|
|
|
612
|
|
|
Unearned revenue
|
|
|
268
|
|
|
|
(4,232
|
)
|
|
Other assets and liabilities
|
|
|
(4,969
|
)
|
|
|
3,471
|
|
|
Net cash provided by (used in) operating activities
|
|
$
|
(208,677
|
)
|
|
$
|
(66,255
|
)
|
|
Cash flows from investing activities:
|
|
|
|
|
|
|
|
Purchases of property and equipment
|
|
|
(7,628
|
)
|
|
|
(14,399
|
)
|
|
Capitalized software development costs
|
|
|
(2,961
|
)
|
|
|
(3,064
|
)
|
|
Purchases of available-for-sale securities
|
|
|
(1,252,367
|
)
|
|
|
(241,162
|
)
|
|
Maturities of available-for-sale securities
|
|
|
407,730
|
|
|
|
318,192
|
|
|
Businesses acquired, net of cash acquired
|
|
|
(13,100
|
)
|
|
|
—
|
|
|
Other investing, net
|
|
|
(5,306
|
)
|
|
|
(1,201
|
)
|
|
Net cash provided by (used in) investing activities
|
|
$
|
(873,632
|
)
|
|
$
|
58,366
|
|
|
Cash flows from financing activities:
|
|
|
|
|
|
|
|
Proceeds from common stock and warrant issuance, net of issuance
costs
|
|
|
1,358,254
|
|
|
|
—
|
|
|
Proceeds from stock options exercised
|
|
|
11,468
|
|
|
|
2,270
|
|
|
Proceeds from warrants exercised
|
|
|
6,708
|
|
|
|
—
|
|
|
Other financing, net
|
|
|
986
|
|
|
|
144
|
|
|
Net cash provided by (used in) financing activities
|
|
$
|
1,377,416
|
|
|
$
|
2,414
|
|
|
Effect of foreign exchange rate changes on cash, cash equivalents
and restricted cash
|
|
|
375
|
|
|
|
4
|
|
|
Net change in cash, cash equivalents and restricted cash
|
|
|
295,482
|
|
|
|
(5,471
|
)
|
|
Cash, cash equivalents and restricted cash at the beginning of the
period
|
|
|
56,840
|
|
|
|
38,081
|
|
|
Cash, cash equivalents and restricted cash at the end of the
period
|
|
$
|
352,322
|
|
|
$
|
32,610
|
|
IonQ, Inc.
Reconciliation of Non-GAAP Financial Measures
(unaudited)
(in thousands, except per share data)
Net Loss to Adjusted EBITDA
|
|
|
Three Months Ended September 30,
|
|
|
Nine Months Ended September 30,
|
|
|
|
|
2025
|
|
|
2024
|
|
|
2025
|
|
|
2024
|
|
|
Net loss attributable to IonQ, Inc.
|
|
$
|
(1,054,955
|
)
|
|
$
|
(52,496
|
)
|
|
$
|
(1,264,045
|
)
|
|
$
|
(129,649
|
)
|
|
Net loss attributable to noncontrolling interests
|
|
|
(657
|
)
|
|
|
—
|
|
|
|
(1,349
|
)
|
|
|
—
|
|
|
Interest income, net
|
|
|
(14,437
|
)
|
|
|
(4,508
|
)
|
|
|
(26,469
|
)
|
|
|
(14,108
|
)
|
|
Interest expense
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
Income tax (benefit) expense
|
|
|
(4,438
|
)
|
|
|
16
|
|
|
|
(19,695
|
)
|
|
|
39
|
|
|
Depreciation and amortization
|
|
|
24,182
|
|
|
|
4,890
|
|
|
|
41,359
|
|
|
|
13,150
|
|
|
Stock-based compensation
|
|
|
72,945
|
|
|
|
24,567
|
|
|
|
205,366
|
|
|
|
67,607
|
|
|
Executive cash-based severance
|
|
|
7,392
|
|
|
|
—
|
|
|
|
7,392
|
|
|
|
—
|
|
|
(Gain) loss on change in fair value of warrant liabilities
|
|
|
881,847
|
|
|
|
3,868
|
|
|
|
882,930
|
|
|
|
(11,398
|
)
|
|
Offering costs associated with warrants
|
|
|
22,847
|
|
|
|
—
|
|
|
|
22,847
|
|
|
|
—
|
|
|
Acquisition transaction and integration costs
|
|
|
16,363
|
|
|
|
—
|
|
|
|
32,303
|
|
|
|
—
|
|
|
Adjusted EBITDA
|
|
$
|
(48,911
|
)
|
|
$
|
(23,663
|
)
|
|
$
|
(119,361
|
)
|
|
$
|
(74,359
|
)
|
Net Loss per Share to Adjusted EPS
|
|
|
Three Months Ended September 30,
|
|
|
|
|
2025
|
|
|
2024
|
|
|
|
|
Amount
|
|
|
Per Share
|
|
|
Amount
|
|
|
Per Share
|
|
|
Net loss per share attributable to IonQ, Inc. common
stockholders
|
|
|
|
|
$
|
(3.58
|
)
|
|
|
|
|
$
|
(0.24
|
)
|
|
Stock-based compensation
|
|
$
|
72,945
|
|
|
|
0.25
|
|
|
$
|
24,567
|
|
|
|
0.11
|
|
|
Executive cash-based severance
|
|
|
7,392
|
|
|
|
0.03
|
|
|
|
—
|
|
|
|
—
|
|
|
(Gain) loss on change in fair value of warrant liabilities
|
|
|
881,847
|
|
|
|
2.99
|
|
|
|
3,868
|
|
|
|
0.02
|
|
|
Offering costs associated with warrants
|
|
|
22,847
|
|
|
|
0.08
|
|
|
|
—
|
|
|
|
—
|
|
|
Acquisition transaction and integration costs
|
|
|
16,363
|
|
|
|
0.06
|
|
|
|
—
|
|
|
|
—
|
|
|
Adjusted EPS
|
|
|
|
|
$
|
(0.17
|
)
|
|
|
|
|
$
|
(0.11
|
)
|
|
|
|
Nine Months Ended September 30,
|
|
|
|
|
2025
|
|
|
2024
|
|
|
|
|
Amount
|
|
|
Per Share
|
|
|
Amount
|
|
|
Per Share
|
|
|
Net loss per share attributable to IonQ, Inc. common
stockholders
|
|
|
|
|
$
|
(4.89
|
)
|
|
|
|
|
$
|
(0.61
|
)
|
|
Stock-based compensation
|
|
$
|
205,366
|
|
|
|
0.79
|
|
|
$
|
67,607
|
|
|
|
0.32
|
|
|
Executive cash-based severance
|
|
|
7,392
|
|
|
|
0.03
|
|
|
|
—
|
|
|
|
—
|
|
|
(Gain) loss on change in fair value of warrant liabilities
|
|
|
882,930
|
|
|
|
3.42
|
|
|
|
(11,398
|
)
|
|
|
(0.05
|
)
|
|
Offering costs associated with warrants
|
|
|
22,847
|
|
|
|
0.09
|
|
|
|
—
|
|
|
|
—
|
|
|
Acquisition transaction and integration costs
|
|
|
32,303
|
|
|
|
0.13
|
|
|
|
—
|
|
|
|
—
|
|
|
Adjusted EPS
|
|
|
|
|
$
|
(0.43
|
)
|
|
|
|
|
$
|
(0.34
|
)
|
Source: IonQ